Organism-dependent fungicidal activities of azoles

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 11, 1998, Pages 3018-3021

  Manavathu, Elias K ^a   Cutright, Jessica L ^a   Chandrasekar, Pranatharthi H ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ITRACONAZOLE; PYRROLE; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; CANDIDA; CELL DEATH; CELL KILLING; CONCENTRATION RESPONSE; CYTOLYSIS; DRUG EFFECT; FUNGICIDAL ACTIVITY; GROWTH INHIBITION; NONHUMAN; PRIORITY JOURNAL;

EID: 0031751639     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.11.3018     Document Type: Article

References (18)

1. Bolard, J. 1986. How do the polyene macrolide antibiotics affect cellular membrane properties? Biochim. Biophys. Acta 864:257-304.
2. Cohn, B. E. 1985. Concentration and time-dependence of amphotericin B induced permeability changes across ergosterol-containing liposomes. Biochim. Biophys. Acta 857:117-122.
3. Elewski, B. E. 1993. Mechanisms of action of systemic antifungal agents. J. Am. Acad. Dermatol. 28:S28-S34.
4. Georgopapadakou, N. H., and T. J. Walsh. 1996. Antifungal agents: chemotherapeutic targets and immunologic strategies. Antimicrob. Agents Chemother. 40:279-291.
5. Heeres, J., L. J. J. Backx, and J. H. Mostmans. 1979. Antimycotic imidazoles. Part 4. Synthesis and antifungal activity of ketoconazole. A new potent orally active broad-spectrum antifungal agent. J. Med. Chem. 22:1003-1005.
6. Lyman, C. A., and T. J. Walsh. 1992. Systemically administered antifungal agents: a review of their clinical pharmacology and therapeutic applications. Drugs 44:9-35.
7. Manavathu, E. K., G. J. Alangaden, and S. A. Lerner. 1996. A comparative study of the broth micro- and macro-dilution techniques for the determination of the in vitro susceptibility of Aspergillus fumigatus. Can. J. Microbiol. 42:960-964.
8. Manavathu, E. K., J. L. Cutright, and P. H. Chandrasekar. 1997. In vitro susceptibility of itraconazole-resistant isolates of Aspergillus fumigatus to voriconazole. Clin. Microbiol. Infect. 3(Suppl. 2):81.
9. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
10. Oakley, K. L., C. B. Moore, and D. W. Denning. 1997. In vitro activity of SCH-56592 and comparison with activities of amphotericin B and itraconazole against Aspergillus spp. Antimicrob. Agents Chemother. 41:1124-1126.
11. Palacios, J., and R. Serano. 1978. Proton permeability induced by polyene antibiotics: a plausible mechanism for their inhibition of maltose fermentation in yeast. FEBS Lett. 91:198-201.
12. Sokol-Anderson, M. L., J. Brajtburg, and G. Medoff. 1986. Amphotericin B-induced oxidation damage and killing of Candida albicans. J. Infect. Dis. 154:76-83.
13. Thomas, A. H. 1986. Suggested mechanisms for the antimycotic activity of the polyene antibiotics and the N-substituted imidazoles. J. Antimicrob. Chemother. 17:269-279.
14. Vanden Bossche, H., D. W. Warnock, B. Dupont, and D. Kerridge. 1994. Mechanisms and clinical impact of antifungal drug resistance. J. Med. Vet. Mvcol. 32:189-202.
15. Vazquez, J. A., M. Lynch, and J. D. Sobel. 1995. In vitro activity of a new pneumocandin antifungal agent, L-733,560 against azole-susceptible and -resistant Candida and Torulopsis species. Antimicrob. Agents Chemother. 39: 2689-2691.
16. Wright, G. D., T. Parent, and J. F. Honek. 1990. Nonsterol structural probes of the lanosterol 14α-demethylase from Saccharomyces cerevisiae. Biochim. Biophys. Acta 1040:95-101.
17. Yoshida, Y., and Y. Aoyama. 1984. Yeast cytochrome P-450 catalyzing lanosterol 14α-demethylation. J. Biol. Chem. 259:1655-1660.
18. 14DM purified from Saccharomyces cerevisiae microsomes. Biochem. Pharmacol. 36:229-235.